Development of a sensitive microarray immunoassay for the quantitative analysis of neuropeptide Y.

A direct competitive immunoassay in an antibody microarray format was developed for the sensitive detection of neuropeptide Y (NPY) and employed in the analysis of NPY in human sweat samples. This is the first demonstration that antibody microarray, as a powerful multiplex analysis tool, can be used for the sensitive determination of NPY and potentially other neuropeptides. 400 pg/mL of dibiotinylated NPY and 0.1 mg/mL spotting capture antibody were found to offer the best performance, yielding a sensitivity of 50 pg/mL and a linear dynamic range of 0.1-100 ng/mL for NPY. Evaluation of matrix effects by using artificial sweat revealed that dialysis is necessary for analyzing NPY in human sweat samples with microarray immunoassay. In a preliminary application, 50-210 pg/mL of NPY was detected in sweat samples collected with Macroduct collectors. This study indicates that antibody microarrays can be used for NPY analysis and that human sweat could be a valuable sample source for biomarker and proteomics studies, especially when noninvasive human sample collection is preferable.

[1]  M. Heilig.  The NPY system in stress, anxiety and depression , 2004, Neuropeptides.

[2]  F. Sundler,et al.  Occurrence and distribution of peptidergic nerve fibers in skin biopsies from patients with systemic sclerosis. , 1996, Acta dermato-venereologica.

[3]  J. Chalmers,et al.  PLASMA NEUROPEPTIDE Y LEVELS RISE IN PATIENTS UNDERGOING EXERCISE TESTS FOR THE INVESTIGATION OF CHEST PAIN , 1986, Clinical and experimental pharmacology & physiology.

[4]  M. Åsberg,et al.  Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. , 2004, Journal of psychiatric research.

[5]  J. Wilkinson,et al.  Effect of beta-chloroethylamine hydrochlorides in leukaemia, Hodgkin's disease, and polycythaemia vera; report on 18 cases. , 1947, Lancet.

[6]  A. Herr,et al.  Antibody microarrays for native toxin detection. , 2005, Analytical biochemistry.

[7]  K. Racaityte,et al.  Analysis of neuropeptide Y and its metabolites by high-performance liquid chromatography-electrospray ionization mass spectrometry and integrated sample clean-up with a novel restricted-access sulphonic acid cation exchanger. , 2000, Journal of chromatography. A.

[8]  F. Hongwen,et al.  Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo. , 1999, Journal of dermatological science.

[9]  R. Funk,et al.  Immunohistochemical detection of human skin nerve fibers. , 1997, Acta Histochemica.

[10]  Esther M. Sternberg,et al.  Elevated Neuroimmune Biomarkers in Sweat Patches and Plasma of Premenopausal Women with Major Depressive Disorder in Remission: The POWER Study , 2008, Biological Psychiatry.

[11]  D. Schaumlöffel,et al.  Absolute peptide quantification by lutetium labeling and nanoHPLC-ICPMS with isotope dilution analysis. , 2009, Analytical chemistry.

[12]  R. Quirion,et al.  Neuropeptide Y (NPY) and depression: from animal studies to the human condition. , 2002, Life sciences.

[13]  G. Ordway,et al.  Reduced Neuropeptide Y Concentrations in Suicide Brain , 1992, Journal of neurochemistry.

[14]  A. Thorsell.  Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety , 2010, Experimental biology and medicine.

[15]  G. Sperk,et al.  Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy? , 2004, Neuropeptides.

[16]  H. Hashimoto,et al.  Plasma neuropeptide Y in patients with major depressive disorder , 1996, Neuroscience Letters.

[17]  I. Christie,et al.  Measurement of cytokines in sweat patches and plasma in healthy women: validation in a controlled study. , 2006, Journal of immunological methods.

[18]  B. Waeber,et al.  A sensitive and specific two-site, sandwich-amplified enzyme immunoassay for neuropeptide Y , 1992, Peptides.

[19]  R. Yehuda,et al.  Plasma Neuropeptide Y Concentrations in Combat Exposed Veterans: Relationship to Trauma Exposure, Recovery from PTSD, and Coping , 2006, Biological Psychiatry.

[20]  E. Hristakieva,et al.  Vitiligo-Related Neuropeptides In Nerve Fibers Of The Skin , 2000, Archives of physiology and biochemistry.

[21]  Claes Wahlestedt,et al.  Therapeutic potential of neuropeptide Y (NPY) receptor ligands , 2010, EMBO molecular medicine.

[22]  C. Cabrele,et al.  Investigation of crudes of synthesis of [Leu31, Pro34]-neuropeptide Y by capillary zone electrophoresis/mass spectrometry. , 1995, Rapid communications in mass spectrometry : RCM.

[23]  K. Tatemoto.  Neuropeptide Y: complete amino acid sequence of the brain peptide. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C Tu,et al.  Levels of neuropeptide-Y in the plasma and skin tissue fluids of patients with vitiligo. , 2001, Journal of dermatological science.

[25]  C. A. Morgan,et al.  Plasma neuropeptide-Y concentrations in humans exposed to military survival training , 2000, Biological Psychiatry.

[26]  R. Quirion,et al.  A possible role of neuropeptide Y in depression and stress , 2010, Brain Research.

[27]  J. Zubieta,et al.  Practical aspects of in vivo detection of neuropeptides by microdialysis coupled off-line to capillary LC with multistage MS. , 2009, Analytical chemistry.

[28]  U. Hellman,et al.  Characterization of Endogenous Neuropeptide Y in Rat Hippocampus and Its Metabolism by Nanospray Mass Spectrometry* , 1997, The Journal of Biological Chemistry.

[29]  P. Schnurr,et al.  Adaptation to extreme stress: post-traumatic stress disorder, neuropeptide Y and metabolic syndrome , 2010, Experimental biology and medicine.

[30]  Lingjiang Li,et al.  CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder , 2006, Brain Research.

[31]  T. Adrian,et al.  NEUROPEPTIDE Y IN PHAEOCHROMOCYTOMAS AND GANGLIONEUROBLASTOMAS , 1983, The Lancet.

[32]  R. Ekman,et al.  Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. , 1992, Journal of psychiatry & neuroscience : JPN.

[33]  Michael G. Roper,et al.  Capillary liquid chromatography of multiple peptides with on‐line capillary electrophoresis immunoassay detection , 2001, Electrophoresis.

[34]  M. Heilig,et al.  Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses , 1990, Acta psychiatrica Scandinavica.

[35]  C. Wahlestedt,et al.  Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. , 1988, Journal of psychiatric research.

[36]  I. Jonsdottir,et al.  Neuropeptides and their interaction with exercise and immune function , 2000 .

[37]  Lei Zhang,et al.  NPY receptors as potential targets for anti‐obesity drug development , 2011, British journal of pharmacology.

[38]  Rémi Quirion,et al.  Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues , 1992, Progress in Neurobiology.

[39]  Stefan W Schneider,et al.  Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. , 2006, Physiological reviews.